| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/1097-0142(19920915)70:4+<1799::AID-CNCR2820701623>3.0.CO;2-B |
| P698 | PubMed publication ID | 1355404 |
| P2093 | author name string | Biedler JL | |
| P2860 | cites work | Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein | Q34040187 |
| Identification of members of the P-glycoprotein multigene family | Q35558945 | ||
| The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues | Q36768537 | ||
| Cloning and characterization of a second member of the mouse mdr gene family | Q36791573 | ||
| Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance | Q36797007 | ||
| Chromosome-mediated gene transfer of multidrug resistance | Q36899033 | ||
| Multidrug resistance of DNA-mediated transformants is linked to transfer of the human mdr1 gene | Q36900119 | ||
| Simultaneous expression of two P-glycoprotein genes in drug-sensitive Chinese hamster ovary cells | Q36923984 | ||
| DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression | Q36974192 | ||
| Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies | Q42812351 | ||
| Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues | Q48913115 | ||
| P433 | issue | 6 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 1799-1809 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Genetic aspects of multidrug resistance. | |
| P478 | volume | 70 |
| Q33665187 | 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis |
| Q34130602 | Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein |
| Q40771515 | Biological characteristics and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines |
| Q43922191 | Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings |
| Q55256341 | Different effects of FK317 on multidrug-resistant tumor in vivo and in vitro. |
| Q48967954 | Ependymomas in children express the multidrug resistance gene: immunohistochemical and molecular biologic study |
| Q38469684 | Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues |
| Q40442652 | Genetic changes in breast cancer -consequences for therapy? |
| Q38011794 | Image-guided nanosystems for targeted delivery in cancer therapy |
| Q42525924 | Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues |
| Q39617875 | Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis |
| Q72526525 | Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs |
| Q41478424 | Modified multiple drug resistance phenotype of Chinese hamster ovary cells selected with X-rays and vincristine versus X-rays only |
| Q40896124 | Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung |
| Q40870179 | Multidrug resistance increment in a human colon carcinoma cell line by colchicine |
| Q28369884 | Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells |
| Q45871082 | P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells |
| Q40380366 | P-glycoprotein: clinical significance and methods of analysis |
| Q38791215 | Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients. |
| Q41015261 | Photoaffinity labels for characterizing drug interaction sites of P-glycoprotein |
| Q38488434 | Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma |
| Q40994555 | Presence of classical multidrug resistance and P-glycoprotein expression in human neuroblastoma cells |
| Q38289006 | Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation |
| Q41013921 | Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells |
| Q47945205 | Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma |
| Q77910931 | Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas |
| Q40630942 | Reverse transformation of multidrug-resistant cells |
| Q37636860 | Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. |
| Q35897342 | Ribozyme-mediated reversal of the multidrug-resistant phenotype |
| Q42207013 | Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines |
| Q36573439 | p53-independent apoptosis induced by paclitaxel through an indirect mechanism |
Search more.